Chung‐Ying Tsai

2.1k total citations
57 papers, 1.6k citations indexed

About

Chung‐Ying Tsai is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Chung‐Ying Tsai has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 14 papers in Cancer Research and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Chung‐Ying Tsai's work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (6 papers). Chung‐Ying Tsai is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (6 papers). Chung‐Ying Tsai collaborates with scholars based in Taiwan, United States and Switzerland. Chung‐Ying Tsai's co-authors include Kwang‐Huei Lin, Hsiang‐Cheng Chi, Ming-Ming Tsai, Chau‐Ting Yeh, Chia‐Siu Wang, Yi‐Hsin Tseng, Yang-Hsiang Lin, I‐Hsiao Chung, Ya‐Hui Huang and Sheng‐Ming Wu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Chung‐Ying Tsai

55 papers receiving 1.6k citations

Peers

Countries citing papers authored by Chung‐Ying Tsai

Since Specialization

Citations

This map shows the geographic impact of Chung‐Ying Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Ying Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Ying Tsai more than expected).

Fields of papers citing papers by Chung‐Ying Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung‐Ying Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Ying Tsai. The network helps show where Chung‐Ying Tsai may publish in the future.

Co-authorship network of co-authors of Chung‐Ying Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Chung‐Ying Tsai. A scholar is included among the top collaborators of Chung‐Ying Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung‐Ying Tsai. Chung‐Ying Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Asparagine deprivation enhances T cell antitumour response in patients via ROS-mediated metabolic and signal adaptations 2025 ·Nature Metabolism ·(unknown), Chung‐Ying Tsai, Cheng-Lung Hsu, Tzong-Shyuan Tai, Mei‐Ling Cheng, Yu‐Ming Chuang, Hsiang-Yu Tang, (unknown), Jia-Jin Chen, Sanders Chang, Yi-Ching Ko, (unknown), Hsuan Liu, Bertrand Chin‐Ming Tan, Chia‐Rui Shen, Chih‐Wei Yang, Ping‐Chih Ho, Huang‐Yu Yang	9
2	SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM 2025 ·Scientific Reports ·Baojun Huang, Chieh‐Li Yen, Chao‐Yi Wu, Chung‐Ying Tsai, Jia‐Jin Chen, (unknown), Yung‐Chang Chen, Ching‐Lin Hsieh, Huang‐Yu Yang	4
3	Blocking pathogenic Leptospira invasion with aptamer molecules targeting outer membrane LipL32 protein 2024 ·Microbes and Infection ·(unknown), Huang‐Yu Yang, Chia‐Chen Chang, (unknown), Chien Li, Ming‐Yang Chang, Yi-Ching Ko, Li‐Fang Chou, Chung‐Ying Tsai, Ya‐Chung Tian, Chih‐Wei Yang	1
4	PPAR-γ agonist pioglitazone and the risks of malignancy among type2 diabetes mellitus patients 2024 ·Acta Diabetologica ·Lai‐Chu See, (unknown), Chung‐Ying Tsai, Cheng‐Chia Lee, (unknown), (unknown), Chao‐Yu Chen, (unknown), Chieh‐Li Yen, Huang‐Yu Yang	3
5	Calreticulin Expression Controls Cellular Redox, Stemness, and Radiosensitivity to Function as a Novel Adjuvant for Radiotherapy in Neuroblastoma 2023 ·Oxidative Medicine and Cellular Longevity ·Chih‐Jung Chen, (unknown), Yueh Chien, Wei-Chieh Huang, Chi‐Sheng Wu, Chung‐Ying Tsai, Yang-Hsiang Lin, Meng‐Shiue Lee, Chian‐Shiu Chien, Yi‐Ping Yang, Meng–Chou Lee, Chung‐Chih Tseng, Hsiang‐Cheng Chi	1
6	Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial Carcinoma 2021 ·Biomedicines ·Chung‐Ying Tsai, Hsiang‐Cheng Chi, Ren‐Chin Wu, Cheng‐Hao Weng, Tzong-Shyuan Tai, Chan‐Yu Lin, Tai‐Di Chen, Yahui Wang, Li‐Fang Chou, (unknown), Po‐Hung Lin, See‐Tong Pang, Huang‐Yu Yang	3
7	Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases 2019 ·Journal of Biomedical Science ·Hsiang‐Cheng Chi, Chung‐Ying Tsai, Ming-Ming Tsai, Chau‐Ting Yeh, Kwang‐Huei Lin	73
8	An interview based approach to the anorectal portion of the International Standards of Neurological Classification of Spinal Cord Injury Exam (I-A-ISNCSCI): a pilot study 2019 ·Spinal Cord ·Audrey Chun, Andrew Delgado, Chung‐Ying Tsai, Lisa Spielman, (unknown), (unknown), Vincent Huang, Stephanie A. Kolakowsky‐Hayner, Miguel X. Escalón, Thomas N. Bryce	4
9	Thyroid hormone negatively regulates tumorigenesis through suppression of BC200 2018 ·Endocrine Related Cancer ·Yang-Hsiang Lin, Meng‐Han Wu, Ya‐Hui Huang, Chau‐Ting Yeh, Hsiang‐Cheng Chi, Chung‐Ying Tsai, Wen‐Yu Chuang, Chia‐Jung Yu, I‐Hsiao Chung, (unknown), Kwang‐Huei Lin	20
10	Taurine up‐regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma 2017 ·Hepatology ·(unknown), Meng‐Han Wu, Ya‐Hui Huang, Chau‐Ting Yeh, Mei‐Ling Cheng, Hsiang‐Cheng Chi, Chung‐Ying Tsai, I‐Hsiao Chung, (unknown), Kwang‐Huei Lin	127
11	Repression of microRNA-130b by thyroid hormone enhances cell motility 2015 ·Journal of Hepatology ·Yang-Hsiang Lin, Meng‐Han Wu, Chia‐Jung Liao, Ya‐Hui Huang, Hsiang‐Cheng Chi, (unknown), Cheng-Yi Chen, Yi‐Hsin Tseng, Chung‐Ying Tsai, I‐Hsiao Chung, Ming-Ming Tsai, (unknown), (unknown), Yung‐Hsin Yeh, Wei-Jan Chen, Kwang‐Huei Lin	47
12	Interleukin-32 Increases Human Gastric Cancer Cell Invasion Associated with Tumor Progression and Metastasis 2014 ·Clinical Cancer Research ·Chung‐Ying Tsai, Chia‐Siu Wang, Ming-Ming Tsai, Hsiang‐Cheng Chi, Wanli Cheng, Yi‐Hsin Tseng, Cheng‐Yi Chen, Crystal D. Lin, (unknown), Lu-Hai Wang, Kwang‐Huei Lin	92
13	MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer 2014 ·Cancer Letters ·Ming-Ming Tsai, Chia‐Siu Wang, Chung‐Ying Tsai, Cheng‐Yi Chen, Hsiang‐Cheng Chi, Yi‐Hsin Tseng, Pei‐Jung Chung, Yang-Hsiang Lin, I‐Hsiao Chung, (unknown), Kwang‐Huei Lin	71
14	Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth 2014 ·International Journal of Cancer ·Sheng‐Ming Wu, Wanli Cheng, Chia‐Jung Liao, Hsiang‐Cheng Chi, (unknown), Yi‐Hsin Tseng, Chung‐Ying Tsai, (unknown), (unknown), (unknown), Yung‐Hsin Yeh, Chi‐Ying F. Huang, (unknown), Yi‐Chen Yeh, Kwang‐Huei Lin	24
15	Thyroid Hormone Regulation of miR-21 Enhances Migration and Invasion of Hepatoma 2013 ·Cancer Research ·Ya-Hui Huang, (unknown), Hsiang‐Cheng Chi, (unknown), (unknown), Sheng‐Ming Wu, Cheng-Yi Chen, Yi‐Hsin Tseng, Chung‐Ying Tsai, (unknown), (unknown), Chi‐Jane Wang, Crystal D. Lin, Kwang‐Huei Lin	50
16	Thyroid hormone receptor inhibits hepatoma cell migration through transcriptional activation of Dickkopf 4 2013 ·Biochemical and Biophysical Research Communications ·Hsiang‐Cheng Chi, (unknown), Ya‐Hui Huang, (unknown), Chung‐Ying Tsai, Chia‐Jung Liao, Yi‐Hsin Tseng, Yang-Hsiang Lin, Cheng‐Yi Chen, I‐Hsiao Chung, Tzu-I Wu, Wei-Jan Chen, Kwang‐Huei Lin	24
17	Overexpression of ADP‐ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance 2012 ·Cancer Science ·Ming‐Ming Tsai, Paul Lin, Wanli Cheng, Chung‐Ying Tsai, Hsiang‐Cheng Chi, Cheng‐Yi Chen, Yi‐Hsin Tseng, (unknown), (unknown), Ying Liang, Chia‐Jung Liao, Sheng‐Ming Wu, (unknown), I‐Hsiao Chung, Chia‐Siu Wang, Kwang‐Huei Lin	24
18	Correction: Glyoxalase-I Is a Novel Prognosis Factor Associated with Gastric Cancer Progression 2012 ·PLoS ONE ·Wanli Cheng, Ming-Ming Tsai, Chung‐Ying Tsai, Yahui Huang, Cheng‐Yi Chen, Hsiang‐Cheng Chi, Yi‐Hsin Tseng, (unknown), Wei-Chi Lin, (unknown), Ying Liang, Chia‐Jung Liao, (unknown), I‐Hsiao Chung, Wen‐Jone Chen, Paul Lin, Chia‐Siu Wang, Kwang‐Huei Lin	18
19	Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC)-based Quantitative Proteomics Study of a Thyroid Hormone-regulated Secretome in Human Hepatoma Cells 2011 ·Molecular & Cellular Proteomics ·Cheng‐Yi Chen, Lang‐Ming Chi, Hsiang‐Cheng Chi, Ming-Ming Tsai, Chung‐Ying Tsai, Yi‐Hsin Tseng, Yang-Hsiang Lin, Wei-Jan Chen, Ya‐Hui Huang, Kwang‐Huei Lin	37
20	Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells 2011 ·Hepatology ·(unknown), Chau‐Ting Yeh, Ya‐Hui Huang, (unknown), Hsiang‐Cheng Chi, Ming-Ming Tsai, Chung‐Ying Tsai, Chia‐Jung Liao, Yi‐Hsin Tseng, Yang-Hsiang Lin, Cheng‐Yi Chen, I‐Hsiao Chung, Wanli Cheng, Wei-Jan Chen, Kwang‐Huei Lin	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact